AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Buying for a business?Offer from Amazon

Get business pricing on office and shipping supplies

  • Business-only prices and quantity discounts
  • Tax-exempt purchasing
  • Multiple users, one account, clear invoices
As an affiliate, we earn on qualifying purchases.

Levi & Korsinsky, a law firm, announced an investigation into whether Xerox adequately disclosed the effects of a $105 million tariff-receivable accounting benefit on its results and guidance. Xerox cut its 2026 adjusted operating-income outlook on Oct. 29 to $450 million-$475 million, below the range it gave in July; the investigation is not a finding of wrongdoing or a filed lawsuit.

Levi & Korsinsky said it is investigating whether Xerox Holdings Corporation adequately disclosed the effect of $105 million in IEEPA tariff receivables on its reported results and 2026 outlook, after Xerox cut that outlook on Oct. 29. The notice concerns potential investor claims; it does not establish that Xerox violated securities laws or that a lawsuit has been filed.

Xerox lowered its full-year 2026 adjusted operating-income outlook to $450 million-$475 million on Oct. 29, according to the law firm’s notice. That range was below the $555 million-$605 million outlook the company announced in July. The notice characterizes the reduction as as much as $130 million relative to the July range.

On July 30, Xerox Chief Financial Officer Chuck Butler said the company’s outlook had increased by $105 million from the prior forecast, primarily because Xerox recognized IEEPA tariff receivables in the second quarter. Xerox’s Form 10-Q, filed with the Securities and Exchange Commission on Aug. 6, recorded a $105 million reduction to cost of sales related to those receivables, according to the notice. The filing described the entry under Note 12, which concerns debt.

Levi & Korsinsky said it is examining whether the company sufficiently explained the nature and implications of the accounting benefit before the October guidance reduction. The firm invited investors who believe they incurred losses to contact it for a review. Investors’ losses or the fact that they held shares do not, by themselves, establish eligibility or prove a legal claim.

At a glance
announcementWhen: Investigation notice issued after Xerox…
The developmentLevi & Korsinsky announced an investor investigation following Xerox’s Oct. 29 reduction to its 2026 adjusted operating-income outlook.

Why the Guidance Reversal Draws Scrutiny

The development matters because the July outlook increase was tied in part to a $105 million accounting benefit, while the October outlook was reduced below the range announced three months earlier. Investors may want to understand how that benefit affected Xerox’s reported operating income and forecast, and what the company disclosed about it at the time.

The legal question described by the firm is whether Xerox’s statements or omissions were materially misleading under securities law. That is an allegation under investigation, not a conclusion. The notice does not report a court ruling, regulatory finding, or established investor recovery. Any eventual claim would depend on evidence, including what Xerox disclosed, when investors bought or sold securities, and the circumstances of any losses.

Products Worth Considering

Logitech MX Master 4 for Mac, Ergonomic Bluetooth Mouse with Haptic Feedback, Ultra-Fast Scrolling, USB-C Charging, for MacOS, iPadOS, Windo

Logitech MX Master 4 for Mac, Ergonomic Bluetooth Mouse with Haptic Feedback, Ultra-Fast Scrolling, USB-C Charging, for MacOS, iPadOS, Windo

As an affiliate, we earn on qualifying purchases.

July Forecast and Tariff Receivables

On July 30, CFO Chuck Butler said adjusted operating income was expected to be $555 million-$605 million, up $105 million from the prior outlook, primarily because of recognizing IEEPA tariff receivables in the second quarter. The notice says the company’s Aug. 6 SEC filing recorded the related $105 million reduction to cost of sales; it also says related financing costs were recorded elsewhere over time.

On Oct. 29, Xerox reduced its 2026 outlook to $450 million-$475 million. The notice compares the new range with the July forecast and says the reduction was as much as $130 million. These figures describe company guidance at different points in time, not final 2026 results. The source material does not provide Xerox’s explanation for the October change beyond the revised outlook itself.

“The firm is investigating whether Xerox may not have adequately disclosed how its tariff-receivable accounting shaped reported results and guidance.”

— Levi & Korsinsky

Questions About Disclosure and Claims

The notice does not establish that Xerox’s disclosures were inaccurate or legally inadequate. It also does not say that Levi & Korsinsky has filed a complaint, identify a court case, or report a regulator’s findings. The company’s response to the investigation notice is not included in the source material.

It remains unclear what drove the full October outlook reduction, how Xerox will ultimately report 2026 results, and whether the law firm will pursue litigation. The notice does not provide the purchase period or other criteria that would determine which investors, if any, could bring a claim. The size of any investor losses and whether those losses are legally recoverable are also not established.

Investor Review and Possible Litigation

Levi & Korsinsky is asking investors with potential losses to contact the firm for an evaluation. The notice lists Joseph E. Levi, Esq., at (212) 363-7500 and provides an email contact. It says investors can gather brokerage statements or trade confirmations showing purchase dates, quantities, prices, and any later sales. Contacting the firm does not establish eligibility or mean a lawsuit will follow.

The next substantive development would be further information from the firm about whether it files an action, or disclosures or results from Xerox that clarify the outlook change and tariff-receivable accounting. No filing date, court proceeding, or next legal milestone is identified in the notice. Investors should distinguish the firm’s investigation announcement from a court-approved case or a determination of liability.

Key Questions

What did Levi & Korsinsky announce?

The firm said it is investigating whether Xerox adequately disclosed the effect of $105 million in IEEPA tariff receivables on its results and 2026 operating-income guidance. The announcement is not a finding of wrongdoing.

What was Xerox’s revised 2026 outlook?

Xerox reduced its full-year adjusted operating-income outlook on Oct. 29 to $450 million-$475 million. Its July range was $555 million-$605 million, according to the notice.

Does the notice mean Xerox has been sued?

No lawsuit or court finding is identified in the supplied notice. It describes an investigation into potential investor claims, and whether litigation will be filed remains unclear.

What records may investors want to gather?

The notice suggests keeping brokerage statements or trade confirmations with purchase dates, share quantities, prices paid, and any subsequent sale dates and prices. Those records may help a law firm review a potential claim but do not guarantee eligibility or recovery.

Source: prnewswire.com

This content is for general information only and is not financial, tax or legal advice. Consult a qualified professional for decisions about your money.
You May Also Like

John Deere owners will get the right to repair equipment under FTC settlement

John Deere owners will gain the right to repair their equipment following an FTC settlement, marking a significant shift in manufacturer repair policies.

A Frontier AI Model Just Went Dark for 18 Days. The Kill-Switch Is Real Now.

An advanced AI model was globally disabled for 18 days after US government order, marking a shift toward government-controlled AI releases amid security concerns.

Briefro: A Document That Tells The Truth

Briefro introduces a new AI-powered document system that guarantees data accuracy, privacy, and brand consistency, running entirely on local hardware.

Sionna Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors Of Pending Investigation Into Sionna Therapeutics (SION)

Levi & Korsinsky informs investors about a pending investigation into Sionna Therapeutics, raising concerns about potential legal actions and company disclosures.